Feasibility of Saliva and Remote Monitoring of Active Cytomegalovirus (CMV) Infection and Symptoms During Ovarian Cancer Treatment

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

49 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-03-07

Study Completion Date

2025-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study evaluates the feasibility and accuracy of using saliva to remotely monitor cytomegalovirus (CMV) infection in individuals receiving treatment for ovarian cancer.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Role of Cytomegalovirus and Inflammation on Patient Symptoms and Outcomes in Ovarian Cancer

NCT03921658

Ovarian Cancer Fallopian Tube Cancer Primary Peritoneal Carcinoma

COMPLETED

Cytomegalovirus Reactivation in Cancer Patients Receiving Chemotherapy

NCT00366717

Cancer Cytomegalovirus

COMPLETED

Cytomegalovirus Control in Critical Care

NCT01503918

Critical Illness

COMPLETED PHASE2

A Study in Adolescent Females to Explore Cytomegalovirus Infection

NCT01691820

Infections, Cytomegalovirus

COMPLETED NA

Cytomegalovirus Vaccine in Healthy Participants

NCT00712634

Precancerous/Nonmalignant Condition

COMPLETED PHASE1

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cancer-related Cognitive Dysfunction Cytomegaloviral Infection Fallopian Tube Carcinoma Ovarian Carcinoma Primary Peritoneal Carcinoma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Observational

Patients undergo saliva sample collection as well as in-clinic or at-home blood sample collection on study. Patients also complete questionnaires, undergo cognitive function testing, and have their medical records reviewed on study.

Non-Interventional Study

Intervention Type OTHER

Non-Interventional Study

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Non-Interventional Study

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age ≥ 18
* Ability to read and write in English
* Diagnosed with ovarian cancer (ovarian, primary peritoneal, fallopian tube)
* Receiving care from providers at Mayo Clinic
* Regardless of diseases status, actively receiving treatment for ovarian cancer (frontline, maintenance, progression, recurrence)

Exclusion Criteria

* Pregnant at the time of study participation
* Inability to provide informed written consent
* History of dementia, stroke, brain tumors or other condition which may impair cognitive functioning

Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No